Board of Directors
Health and medical research and its translation into evidence-based clinical practice, public health policy and health services delivery are vital for the continued advancement of human health and wellbeing. As Sri Lanka’s pioneering clinical trials management company, RemediumOne plays a critical role in supporting the broad range of research activities needed to address current and future health challenges in partnership with key stakeholders in the country and collaborators around the world.
Sri Lanka’s clinical research environment like any other market is expected to change dramatically over the coming years, but our overriding philosophy of placing clients and quality at the heart of everything we do will remain unchanged. As we head towards 2019, our 10th anniversary and beyond, we will continue to transform ourselves and take on new challenges with the aim of creating a solid operating platform that can deliver consistent results under any circumstance.
As an innovation-led organization focused on providing high-qulaity clinical trial management services, we have leveraged our inherent strengths in project coordination and implementation with those of our academic partner to successfully conduct a diverse portfolio of hospital- and community-based clinical research projects. The desire for excellence of our staff at RemediumOne who have never been afraid of change or taking on new challenges is at the heart of our success. We believe our human capital input makes the biggest difference in delivering excellent results consistently across projects in varied therapeutic areas.
Looking ahead, we are entering an era in which conventional wisdom will be increasingly challenged and the healthcare industry will also see considerable changes. No matter what the future holds, RemediumOne will expand our focus with an eye on helping solve the issues of our research partners and continue to be relevant to society.
Recently appointed as Director of RemediumOne Private Limited, Mr. Samantha Ranatunga has a wealth of experience in a variety of industries. He also held the position as Chairman of the Ceylon Chamber of Commerce. Mr. Ranatunga has worked for 30 years at the CIC Group and of it 10 years as its Managing Director and CEO. Mr. Ranatunga also served as an independent director at the Seylan Bank Board for 9 years. His desire to reconnect with the field of science and technology aided his decision to join a center of scientific excellence such as RemediumOne. Using his experience as a pioneer in coordinating and setting up agricultural and pharmaceutical businesses of CIC, Mr. Ranatunga will help our quest to strategically build and position RemediumOne in the global clinical trial industry to create further business opportunities for the organization and its potential stakeholders.
Priyanga Gunasekera has almost twenty years of experience in all aspects of sales and marketing and business management in Information Technology. He has a BSc (Hon) degree in Computer Science from University of Colombo and since been involved in the IT sector at various levels.
After starting his career as a Systems Engineers, he rose to be a Director of Informatics (Pvt) Ltd., a position that he held until March 31, 2011. Currently he is the Managing Director of V S information Systems (Pvt) Ltd. a leading Information Technology company in Sri Lanka.
During his career, he has held positions in several industry organisations such as the Sri Lanka Computer Vendors Association, (SLCVA) and Sri Lanka Association of Software and Service Companies (SLASSCOM) and was the Chairman of the IT Sector of the National Chamber of Commerce of Sri Lanka (NCCSL) from 2008 to 2010.
Karthi Gajendran is currently President, Airport Development for GVK Group, one of the largest private airport operators in Asia. In addition to overseeing the multibillion dollar development of airports in India, he is responsible for GVK’s international strategy and investments and the operations in Indonesia managing the redevelopment of Ngurah Rai International Airport in Bali, and construction of a new green field airport in Yogyakarta, Indonesia.
Prior to joining GVK in 2010, he was a Senior Vice President at CH2M HILL, a Fortune 500, global leader in full-service engineering, construction, procurement and program management firm. Based in London, he spent 10 years as the Commercial & Operations Director for Europe & Middle East operations and also served as a Board Director for a number of CH2M HILL’s subsidiaries.
He has also worked at WPP Group PLC, the global leader in marketing services and their subsidiary Hill & Knowlton as the Chief Financial Officer for Central & Eastern European operations in London and Brussels for almost 10 years. He holds a post graduate certificate in economics from Birkbeck College, University of London and is a Fellow Chartered Management Accountant (FCMA), United Kingdom.
Mr. Wickramasuriya joined the upstream oil and gas industry in 1984, working for Schlumberger, the world’s largest petroleum services company. Following 20 years in oil exploration worldwide, he returned to Sri Lanka in 2004, where he was appointed Chairman/Director General of the Sri Lanka Board of Investment.
Thereafter, he was appointed Chairman of the Sri Lanka Ports Authority, in which capacity he negotiated and commenced the Colombo Port Expansion and Hambantota Port Phase 1 projects. He retired from Government service in June 2017 after spending the previous 6 years as the Director General of the Petroleum Resources Development Secretariat, an institution tasked with developing the country’s emerging upstream petroleum industry.
Mr. Wickramasuriya is currently Co-Chair of the National Agenda Committee on Energy of the Ceylon Chamber of Commerce, and a consultant to the Ministry of Energy. In these capacities he is assisting the Minister of Energy in his initiative to introduce policy targeting net-zero carbon emission for Sri Lanka by 2050. Mr Wickramasuriya is also in the newly formed Colombo Port City Economic Commission, where he serves as Acting Director General in addition to his role as Commission Member.